Prognostic value of mayo 2012 vs. european‑modified mayo 2004 staging in AL amyloidosis patients with discordant stage classifications

Miran Han(Ajou University), Kihyun Kim(Samsung Medical Center), Jung Eun Lee(Samsung Medical Center), Jung‐Sun Kim(Yonsei University), Ju‐Hong Min(Samsung (South Korea)), Sang Eun Yoon(Samsung Medical Center), Jin-Oh Choi(Samsung Medical Center), Byoung Joon Kim(Samsung Medical Center), Seok‐Jin Kim(Samsung Medical Center), Darae Kim(British Heart Foundation)
Blood
November 3, 2025
10.1182/blood-2025-5738
Cited by 0

Related Papers

A New Strategy for Discontinuation of Dual Antiplatelet Therapy
|Journal of the American College of Cardiology|2012|643
Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation
|JAMA|2015|603
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
|JAMA|2020|548
Optical coherence tomography in coronary atherosclerosis assessment and intervention
|Nature Reviews Cardiology|2022|397
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|356